139
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Susceptibility of Genetic Variations in Methylation Pathway to Gastric Cancer

, , , , , , , ORCID Icon, & ORCID Icon show all
Pages 441-448 | Published online: 04 May 2022

References

  • Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–648. doi:10.1016/S0140-6736(20)31288-5
  • den Hoed CM, Kuipers EJ. Gastric cancer: how can we reduce the incidence of this disease? Curr Gastroenterol Rep. 2016;18(7):34. doi:10.1007/s11894-016-0506-0
  • Rawla P, Barsouk A. Epidemiology of gastric cancer: global trends, risk factors and prevention. Przegladgastroenterologiczny. 2019;14(1):26–38. doi:10.5114/pg.2018.80001
  • Ling ZQ, Ge MH, Lu XX, et al. Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma. Oncotarget. 2015;6(10):8210–8225. doi:10.18632/oncotarget.3601
  • Chang X, Ma J, Xue X, et al. DNMT family induces down-regulation of NDRG1 via DNA methylation and clinicopathological significance in gastric cancer. PeerJ. 2021;9:e12146. doi:10.7717/peerj.12146
  • Takano H, Shibata T, Nakamura M, et al. Effect of DNMT3A polymorphisms on CpG island hypermethylation in gastric mucosa. BMC Med Genet. 2020;21(1):205. doi:10.1186/s12881-020-01142-7
  • Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247–257. doi:10.1016/s0092-8674(00)81656-6
  • Toyota M, Yamamoto E. DNA methylation changes in cancer. Prog Mol Biol Transl Sci. 2011;101:447–457. doi:10.1016/B978-0-12-387685-0.00014-7
  • Supic G, Kozomara R, Zeljic K, Jovic N, Magic Z. Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients. Clin Oral Investig. 2017;21(1):173–182. doi:10.1007/s00784-016-1772-9
  • Levine AJ, Lee W, Figueiredo JC, et al. Variation in folate pathway genes and distal colorectal adenoma risk: a sigmoidoscopy-based case-control study. Cancer Causes Control. 2011;22(4):541–552. doi:10.1007/s10552-011-9726-7
  • Yan S, Xu D, Wang P, et al. MTHFR C677T polymorphism contributes to the risk for gastric cancer. Tumourbiology. 2014;35(3):2123–2132. doi:10.1007/s13277-013-1282-1
  • Si PR, Fang DC, Zhang H, Yang LQ, Luo YH, Liao HY. [The relationship between methylenetetrahydrofolate reductase gene polymorphism and microsatellite instability in gastric cancer]. Zhonghua liu xingbingxue za zhi. 2005;26(10):794–799. Chinese.
  • He B, Pan B, Pan Y, et al. IL-4/IL-4R and IL-6/IL-6R genetic variations and gastric cancer risk in the Chinese population. Am J Transl Res. 2019;11(6):3698–3706.
  • Winkelmann J, Lin L, Schormair B, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet. 2012;21(10):2205–2210. doi:10.1093/hmg/dds035
  • Milutinovic S, Brown SE, Zhuang Q, Szyf M. DNA methyltransferase 1 knock down induces gene expression by a mechanism independent of DNA methylation and histone deacetylation. J Biol Chem. 2004;279(27):27915–27927. doi:10.1074/jbc.M312823200
  • Vernier M, McGuirk S, Dufour CR, et al. Inhibition of DNMT1 and ERRalpha crosstalk suppresses breast cancer via derepression of IRF4. Oncogene. 2020;39(41):6406–6420. doi:10.1038/s41388-020-01438-1
  • Tang H, Deng M, Tang Y, et al. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin Cancer Res. 2013;19(20):5602–5612. doi:10.1158/1078-0432.CCR-13-1326
  • Yoon JH, Choi YJ, Choi WS, et al. GKN1-miR-185-DNMT1 axis suppresses gastric carcinogenesis through regulation of epigenetic alteration and cell cycle. Clin Cancer Res. 2013;19(17):4599–4610. doi:10.1158/1078-0432.CCR-12-3675
  • Ning X, Shi Z, Liu X, et al. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression. Cancer Lett. 2015;359(2):198–205. doi:10.1016/j.canlet.2015.01.005
  • Sun M, Nie F, Wang Y, et al. LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1, and DNMT1. Cancer Res. 2016;76(21):6299–6310. doi:10.1158/0008-5472.CAN-16-0356
  • Wang HC, Chen CW, Yang CL, et al. Tumor-associated macrophages promote epigenetic silencing of gelsolin through DNA methyltransferase 1 in gastric cancer cells. Cancer Immunol Res. 2017;5(10):885–897. doi:10.1158/2326-6066.CIR-16-0295
  • Mutze K, Langer R, Schumacher F, et al. DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer. Eur J Cancer. 2011;47(12):1817–1825. doi:10.1016/j.ejca.2011.02.024
  • Kullmann K, Deryal M, Ong MF, Schmidt W, Mahlknecht U. DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population. Clin Epigenetics. 2013;5(1):7. doi:10.1186/1868-7083-5-7
  • Chang SC, Chang PY, Butler B, et al. Single nucleotide polymorphisms of one-carbon metabolism and cancers of the esophagus, stomach, and liver in a Chinese population. PLoS One. 2014;9(10):e109235. doi:10.1371/journal.pone.0109235
  • Yang XX, He XQ, Li FX, Wu YS, Gao Y, Li M. Risk-association of DNA methyltransferases polymorphisms with gastric cancer in the Southern Chinese population. Int J Mol Sci. 2012;13(7):8364–8378. doi:10.3390/ijms13078364
  • Jia Z, Wu X, Cao D, et al. Polymorphisms of the DNA Methyltransferase 1 gene predict survival of gastric cancer patients receiving tumorectomy. Dis Markers. 2016;2016:8578064. doi:10.1155/2016/8578064
  • Hu F, Li X, Li X, et al. Lack of association between DNMT1 gene polymorphisms and noise-induced hearing loss in a Chinese population. Noise Health. 2013;15(65):231–236. doi:10.4103/1463-1741.113517
  • Sun MY, Yang XX, Xu WW, Yao GY, Pan HZ, Li M. Association of DNMT1 and DNMT3B polymorphisms with breast cancer risk in Han Chinese women from South China. Gene Mol Res. 2012;11(4):4330–4341. doi:10.4238/2012.September.26.1
  • Maric H, Supic G, Kandolf-Sekulovic L, et al. DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients. Melanoma Res. 2019;29(6):596–602. doi:10.1097/CMR.0000000000000612